Liraglutide and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery
Authors
- Paul R. Burton (ORCID: https://orcid.org/0000-0001-5799-9634)
- Cheryl Laurie
- Yazmin Johari (ORCID: https://orcid.org/0000-0002-1531-9749)
- Eldho Paul (ORCID: https://orcid.org/0000-0003-1263-7255)
- John M. Wentworth (ORCID: https://orcid.org/0000-0002-5197-3529)
- Michael A. Cowley (ORCID: https://orcid.org/0000-0001-7811-134X)
- Wendy A. Brown
Institutions
- The Royal Melbourne Hospital (AU)
- Alfred Health (AU)
- Monash University (AU)
Funders
- Eli Lilly and Company
- Pfizer
- Novo Nordisk
- Medical Research Council
- National Health and Medical Research Council